Specific potentiation of endothelium-dependent contractions in SHR by tetrahydrobiopterin

Hypertension

Volumn 41, Issue 1, 2003, Pages 136-142

  Yang, Di ^a,b   Levens, Nigel ^c   Zhang, Ji Nan ^a   Vanhoutte, Paul M ^d   Félétou, Michel ^c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSTITUT DE RECHERCHES SERVIER   (France)

^d INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Endothelium dependent contractions; Nitric oxide; Rats, spontaneously hypertensive; Tetrahydrobiopterin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 [[6 AMINO (4 CHLOROBENZENESULFONYL) 2 METHYL 5,6,7,8 TETRAHYDRONAPHT] 1 YL]PROPIONIC ACID; ACETYLCHOLINE; CATALASE; CYCLOOXYGENASE 1 INHIBITOR; DIHYDROBIOPTERIN; FREE RADICAL; N(G) NITROARGININE; PHENYLEPHRINE; PTERIDINE DERIVATIVE; SALICYLIC ACID DERIVATIVE; SCAVENGER; SEPIAPTERIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN; TIRON; UNCLASSIFIED DRUG; XANTHINE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; AUTOOXIDATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; ISOLATED ORGAN; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; AORTA; BIOPTERIN; CULTURE TECHNIQUES; DITHIOTHREITOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPERTENSION; NITRIC OXIDE SYNTHASE; NITROARGININE; PTERIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; REDUCING AGENTS; VASOCONSTRICTION; VASODILATION;

EID: 0037219687     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000047669.93078.A7     Document Type: Article

References (30)

1. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
2. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension. 1989;13:859-864.
3. Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol. 1986;250: H815-H821.
4. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun. 1993;18:195-199.
5. Yang D, Félétou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM. Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol. 2002;136:104-110.
6. Cosentino F, Lüscher TF. Tetrahydrobiopterin and endothelial nitric oxide synthase activity. J Cardiovasc Res. 1999;43:274-278.
7. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol. 2001;281:H981-H986.
8. Mayer B, Werner ER. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn Schmiedebergs Arch Pharmacol. 1995;351:453-463.
9. Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol. 1997;29:8-15.
10. Stores E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Lüscher TF, Rabelink TJ. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest. 1997;99:41-46.
11. Maier W, Cosentino F, Lutolf RB, Fleisch M, Seiler C, Hess OM, Meier B, Lüscher TF. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol. 2000;35:173-178.
12. Hong HJ, Hsiao G, Cheng TH, Yen MH. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension. 2001;38:1044-1048.
13. Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Lüscher TF. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest. 1998;101:1530-1537.
14. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension. 1999;33:1353-1358.
15. Koga T, Takata Y, Kobayashi K, Takishita S, Yamashita Y, Fujishima M. Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat. Hypertension. 1989;14:542-548.
16. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension. 1992;19:442-445.
17. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BSS, Karoui H, Tordo P Pritchard KA. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA. 1998;95:9220-9225.
18. Tiefenbacher CP. Tetrahydrobiopterin. a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction. Am J Physiol. 2001;280:H2484-H2488.
19. Wever RMF, van Dam T, van Rijn HJM, de Groot F, Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophysic Res Comm. 1997;237:340-344.
20. Gorren ACF, Mayer B. Tetrahydrobiopterin in nitric oxide synthesis: a novel biological role for pteridines. Curr Drug Metabol. 2002;3:133-157.
21. Hyun J, Komori Y, Chauduri G, Ignarro LJ, Fukuto JM. The protective effect of tetrahydrobiopterin on the nitric oxide-mediated inhibition of purified nitric oxide synthase. Biochem Biophys Res Commun. 1995;206:380-386.
22. Vasquez-Vivar J, Martasek P, Whitsett J, Joseph J, Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J. 2002;362:733-739.
23. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxinitrite and tetrahydrobiopterin. Circulation. 2001;103:1282-1288.
24. Mayer B, Klatt P, Werner ER, Schmidt K. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem. 1995;270:655-659.
25. Klatt P, Schmid M, Leopold E, Schmidt K, Werner EB, Mayer B. The pteridine binding site of brain nitric oxide synthase: tetrahydrobiopterin binding kinetics, specificity and allosteric interaction with the substrate domain. J Biol Chem. 1994;269:13861-13866.
26. Kinoshita H, Katuzic ZS. Exogenous tetrahydrobiopterin causes endothelium-dependent contractions in isolated basilar artery. Am J Physiol. 1996;271:H738-H743.
27. Tsutsui M, Milstien S, Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res. 1996;79:336-342.
28. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension. 1990;15:699-703.
29. Johnson JL, Wimsatt J, Buckel SD, Dyer RD, Maddipati KR. Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons. Arch Biochem Biophys. 1995;324:26-34.
30. Simonet S, Descombes JJ, Vallez MO, Dubuffet T, Lavielle G, Verbeuren TJ. S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig. In:- Sinzinger H, Samuelson B, Vane JR, Paoletti R, Ramwell P, Wang PY-K, eds. Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research. New York, NY: Plenum Press; 1998:173-176.